The preliminary data released today appear to support the bullish view of PSI-7977 because patients were able to achieve a so-called rapid virologic response, or RVR, with and without injectable interferon. Eliminating interferon also reduced side effects and toxicity, according to the abstract. All the patients enrolled in the study were genotype 2 and 3, a less common and more easily treated variant of hepatitis C.
pharmasset is on a roll offers 100% cure rate, page-15
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
-0.001(5.00%) |
Mkt cap ! $17.14M | |||
| Open | High | Low | Value | Volume |
| 1.9¢ | 1.9¢ | 1.9¢ | $5.671K | 298.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 512798 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 1050263 | 5 |
View Market Depth
| Last trade - 15.59pm 04/10/2024 (20 minute delay) ? |
| BIT (ASX) Chart |